Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CAR-T Meeting 2024 | The future of CAR-T for hematological malignancies and solid tumors

Alex Rampotas • 15 Feb 2024
CAR-T Meeting 2024
General CAR-T

In this video, Alex Rampotas, MD, University College London, London, UK, briefly discusses how the rise of CAR T-cell therapy may change the field of hematological oncology. Dr Rampotas also hopes this revolutionary treatment option will exhibit positive results when tested in solid tumors. This interview took place at the EBMT-EHA 6th European CAR T-cell Meeting in Valencia, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Conference fees: Gilead.

More from Alex Rampotas

Key findings from a European survey on allogeneic transplantation for myelofibrosis
2:41
Key findings from a European survey on allogeneic transplantation for myelofibrosis
Alex Rampotas • 24 Mar 2026
The rapidly evolving field of CAR-T: developing approaches for MF, autoimmune disease & solid tumors
4:27
The rapidly evolving field of CAR-T: developing approaches for MF, autoimmune disease & solid tumors
Alex Rampotas • 24 Mar 2026
The upcoming EBMT-EHA European CAR T-cell meeting 2026: sharing updates in CAR-T & cellular therapy
2:16
The upcoming EBMT-EHA European CAR T-cell meeting 2026: sharing updates in CAR-T & cellular therapy
Alex Rampotas • 28 Jan 2026
Development and evaluation of a first-in-class CAR-T therapy against calreticulin-mutant neoplasms
8:03
Development and evaluation of a first-in-class CAR-T therapy against calreticulin-mutant neoplasms
Alex Rampotas et al. • 7 Dec 2024

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals